A lipid-desaturating enzyme offers a new drug target for Parkinson’s disease
Monday, December 10, 2018 - 16:20
in Biology & Nature
Two teams of scientists independently discovered that inhibiting an enzyme called stearoyl-CoA desaturase reduces the toxicity of α-synuclein, a protein implicated in Parkinson’s disease